SCHEMBL2913142

SCHEMBL2913142

COc1ccc(C(C(=O)NC2CCCCC2)C2(C(OC)C3CCCCC3)Nc3cc(F)c(Cl)cc3N2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
MAPK1 P28482 1/20 0.43
CYP2C19 P33261 1/20 0.43
CNR1 P21554 1/20 0.41
CNR2 P34972 1/20 0.41
YAP1 P46937 4/20 0.41
TEAD4 Q15561 4/20 0.41
HTT P42858 1/20 0.39
MAPT P10636 1/20 0.39
PKM P14618 1/20 0.39
LMNA P02545 1/20 0.39
TSHR P16473 1/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
NPSR1 Q6W5P4 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2912870 1.00 ALDH1A1 (0.43) ALDH1A1CYP3A4CYP2D6MAPK1CYP2C19
SCHEMBL2913981 0.94 ALDH1A1 (0.46) ALDH1A1CYP3A4CYP2D6MAPK1CYP2C19
SCHEMBL2912667 0.94 ALDH1A1 (0.46) ALDH1A1CYP3A4CYP2D6MAPK1CYP2C19
SCHEMBL2906333 0.88 YAP1 (0.43) ALDH1A1CYP3A4CYP2D6MAPK1CYP2C19
SCHEMBL2909713 0.87 CNR1 (0.39) CYP3A4CNR1CNR2LMNATSHR
SCHEMBL2912956 0.87 CNR1 (0.39) CYP3A4CNR1CNR2LMNATSHR
SCHEMBL2913081 0.87 YAP1 (0.42) ALDH1A1CYP3A4CYP2D6MAPK1CYP2C19
SCHEMBL2915685 0.83 NPC1 (0.39) CNR1CNR2LMNATSHRNPC1
SCHEMBL2913502 0.81 YAP1 (0.44) ALDH1A1CYP3A4CYP2D6MAPK1CYP2C19
SCHEMBL2914662 0.80 MAPT (0.44) ALDH1A1CYP3A4CYP2D6MAPK1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2222645-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. Hoffmann-La Roche AG (CH) 2010-09-01 EP disclosed
WO-2009062874-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2009-05-22 WO disclosed